Carla Ml van Herpen

13PUBLICATIONS
105CO-AUTHORS
Solid tumoursPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 07, 2026
Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer.

|Jul 15, 2025
The effect of androgen blockade on [68Ga]Ga-PSMA-11 and [18F]FDG PET uptake in patients with recurrent or metastatic salivary duct carcinoma: a prospective imaging study.

Niels J van Ruitenbeek, Maike J M Uijen, Chantal M L Driessen

|Jul 09, 2025
Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.

Stefan G van Ravensteijn, Jacco J de Haan, Hans Gelderblom

|Feb 18, 2025
COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts.

Sumanta K Pal, Yohann Loriot, Andrea Necchi

|Jul 18, 2024
The Innate Immune Landscape of dMMR/MSI Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol.

Laurien J Zeverijn, Birgit S Geurts, Thomas W Battaglia

|May 15, 2024
Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.

Birgit S Geurts, Laurien J Zeverijn, Jade M van Berge Henegouwen

Pageof 3

Frequent Collaborators

5 joint publications

Hans Gelderblom

4 joint publications

Henk Mw Verheul

4 joint publications

Jade M van Berge Henegouwen

4 joint publications

Hanneke van der Wijngaart